Dataset Information

5-HT4 receptors constitutively promote the non-amyloidogenic pathway of APP cleavage and interact with ADAM10.

ABSTRACT: In addition to the amyloidogenic pathway, amyloid precursor protein (APP) can be cleaved by ?-secretases, producing soluble and neuroprotective APP alpha (sAPP?) (nonamyloidogenic pathway) and thus preventing the generation of pathogenic amyloid-?. However, the mechanisms regulating APP cleavage by ?-secretases remain poorly understood. Here, we showed that expression of serotonin type 4 receptors (5-HT(4)Rs) constitutively (without agonist stimulation) induced APP cleavage by the ?-secretase ADAM10 and the release of neuroprotective sAPP? in HEK-293 cells and cortical neurons. This effect was independent of cAMP production. Interestingly, we demonstrated that 5-HT(4) receptors physically interacted with the mature form of ADAM10. Stimulation of 5-HT(4) receptors by an agonist further increased sAPP? secretion, and this effect was mediated by cAMP/Epac signaling. These findings describe a new mechanism whereby a GPCR constitutively stimulates the cleavage of APP by ?-secretase and promotes the nonamyloidogenic pathway of APP processing.

SUBMITTER: Cochet M

PROVIDER: S-EPMC3547471 | biostudies-literature | 2013 Jan

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

5-HT4 receptors constitutively promote the non-amyloidogenic pathway of APP cleavage and interact with ADAM10.

Cochet Maud M Donneger Romain R Cassier Elisabeth E Gaven Florence F Lichtenthaler Stefan F SF Marin Philippe P Bockaert Joël J Dumuis Aline A Claeysen Sylvie S

ACS chemical neuroscience 20121013 1

In addition to the amyloidogenic pathway, amyloid precursor protein (APP) can be cleaved by α-secretases, producing soluble and neuroprotective APP alpha (sAPPα) (nonamyloidogenic pathway) and thus preventing the generation of pathogenic amyloid-β. However, the mechanisms regulating APP cleavage by α-secretases remain poorly understood. Here, we showed that expression of serotonin type 4 receptors (5-HT(4)Rs) constitutively (without agonist stimulation) induced APP cleavage by the α-secretase AD ...[more]

PMID: 23336052

Similar Datasets

Project description:Alzheimer's disease (AD) is characterized by an accumulation of Amyloid-? (A?), released by sequential proteolytic processing of the amyloid precursor protein (APP) by ? - and ?-secretase. A? peptides can aggregate, leading to toxic A? oligomers and amyloid plaque formation. A? accumulation is not only dependent on de novo synthesis but also on A? degradation. Neprilysin (NEP) is one of the major enzymes involved in A? degradation. Here we investigate the molecular mechanism of NEP regulation, which is up to now controversially discussed to be affected by APP processing itself. We found that NEP expression is highly dependent on the APP intracellular domain (AICD), released by APP processing. Mouse embryonic fibroblasts devoid of APP processing, either by the lack of the catalytically active subunit of the ?-secretase complex [presenilin (PS) 1/2] or by the lack of APP and the APP-like protein 2 (APLP2), showed a decreased NEP expression, activity and protein level. Similar results were obtained by utilizing cells lacking a functional AICD domain (APP?CT15) or expressing mutations in the genes encoding for PS1. AICD supplementation or retransfection with an AICD encoding plasmid could rescue the down-regulation of NEP further strengthening the link between AICD and transcriptional NEP regulation, in which Fe65 acts as an important adaptor protein. Especially AICD generated by the amyloidogenic pathway seems to be more involved in the regulation of NEP expression. In line, analysis of NEP gene expression in vivo in six transgenic AD mouse models (APP and APLP2 single knock-outs, APP/APLP2 double knock-out, APP-swedish, APP-swedish/PS1?exon9, and APP?CT15) confirmed the results obtained in cell culture. In summary, in the present study we clearly demonstrate an AICD-dependent regulation of the A?-degrading enzyme NEP in vitro and in vivo and elucidate the underlying mechanisms that might be beneficial to develop new therapeutic strategies for the treatment of AD.

Dataset Information

5-HT4 receptors constitutively promote the non-amyloidogenic pathway of APP cleavage and interact with ADAM10.

Publications

5-HT4 receptors constitutively promote the non-amyloidogenic pathway of APP cleavage and interact with ADAM10.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure